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Abstract
The myelin sheaths that surround the thick axons of the peripheral nervous system are produced by the highly specialized
Schwann cells. Differentiation of Schwann cells and myelination occur in discrete steps. Each of these requires coordinated
expression of specific proteins in a precise sequence, yet the regulatory mechanisms controlling protein expression during
these events are incompletely understood. Here we report that Schwann cell-specific ablation of the enzyme Dicer1, which
is required for the production of small non-coding regulatory microRNAs, fully arrests Schwann cell differentiation, resulting
in early postnatal lethality. Dicer2/2 Schwann cells had lost their ability to myelinate, yet were still capable of sorting axons.
Both cell death and, paradoxically, proliferation of immature Schwann cells was markedly enhanced, suggesting that their
terminal differentiation is triggered by growth-arresting regulatory microRNAs. Using microRNA microarrays, we identified
16 microRNAs that are upregulated upon myelination and whose expression is controlled by Dicer in Schwann cells. This set
of microRNAs appears to drive Schwann cell differentiation and myelination of peripheral nerves, thereby fulfilling a crucial
function for survival of the organism.
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Introduction
Proper myelination is essential for the efficient saltatory
conduction of action potentials, the trophic support of axons,
and the maintenance of axonal integrity in the peripheral nervous
system (PNS). Defective PNS myelination occurs in hereditary
peripheral neuropathies [1]. Sporadic peripheral neuropathies can
arise due to a wide variety of factors, including metabolic disorders
(e.g. diabetes mellitus), intoxication (e.g. alcohol), and autoimmune
disorders (e.g. Guillain-Barre´ syndrome) [2]. Treatment of
peripheral neuropathies is still unsatisfactory in most cases, and
is likely to benefit from increased knowledge about peripheral
myelin development and maintenance.
The mature myelin sheaths wrapped around the large-diameter
axons of peripheral neurons arise from neural crest cells which
subsequently develop into Schwann cell precursors (SCPs),
immature Schwann cells, and finally mature myelinating or non-
myelinating Schwann cells. Each stage of Schwann cell develop-
ment is associated with a set of specific protein markers, the
expression of which is thought to be driven primarily by axon-
derived signals at the SCP stage and by the secretion of autocrine
survival factors at the Schwann cell stage (reviewed in [3]). This
precise developmental program requires tightly regulated tran-
scriptional and post-transcriptional control of protein expression,
the details of which are still incompletely understood.
One post-transcriptional mechanism that appears to be critical
for the proper development of numerous tissues is the microRNA
(miRNA) system [4]. miRNAs are short (20–30 nucleotides) non-
coding RNAs which are processed from endogenously expressed
pri-miRNAs by the enzyme Drosha. The resulting stem-loop pre-
miRNAs are exported to the cytoplasm where they are further
processed by the enzyme Dicer [5], unwound into single-stranded
miRNAs, and loaded into the RNA-induced silencing complex
(RISC). The miRNA-loaded RISC then binds to complementary
miRNA recognition sequences in the 39untranslated regions
(UTRs) of specific target mRNAs. The primary function of the
miRNA system appears to consist of mRNA silencing. Target
mRNAs are either degraded, or their translation is inhibited. A
single miRNA can have multiple mRNA targets, which allows for
broad miRNA-mediated regulation of expression programs
(reviewed in [6]). Genetic ablation of Dicer in mice is embryonic
lethal, illustrating the indispensable role that miRNAs play during
development [7]. Furthermore, studies utilizing tissue-specific
expression systems have revealed a vital role for miRNAs in the
development of specific organ systems (reviewed in [8]). In the
nervous system, miRNAs appear to be important for the
development of Purkinje [9] and forebrain [10] neurons,
oligodendrocyte differentiation and central nervous system
(CNS) myelination [11,12,13], and as shown more recently, also
for peripheral myelination by Schwann cells [14].
In order to determine which miRNAs might be required for
peripheral myelination, we created a mouse line undergoing
Schwann cell-specific deletion of Dicer1, by crossing mutants
whose endogenous Dicer1 sequences were flanked by floxP sites
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(Dicer1fl/fl) to mice expressing the Cre recombinase under the
control of the desert hedgehog promoter (Dhh-Cre).
Results
Dicer depletion in Schwann cells leads to arrest at the
pro-myelin stage and impairs myelination
In order to achieve Schwann cell-specific deletion of the
enzyme Dicer, we bred Dicerfl/fl mice to mice expressing Cre-
recombinase specifically in Schwann cells (tgDhh-Cre, henceforth
termed Dhh-Cre+). The Cre recombinase in these mice is already
active in Schwann cells of the precursor stage at embryonic day
12/13 (E12/13) [15]. In contrast to their littermates, Dicerfl/fl
Dhh-Cre+ mice lacking Dicer expression in Schwann cells
exhibited a severe behavioral phenotype characterized by ataxia
and hind limb paresis. In compliance with animal welfare
regulations, mice were euthanized at the age of 25 days. Electron
microscopy (EM) of 18-day old Dicerfl/fl Dhh-Cre+ sciatic nerves
revealed a severe myelination defect when compared to control
littermates Dicerwt/fl Dhh-Cre+ and Dicerfl/fl Dhh-Cre2. In
Dicerfl/fl Dhh-Cre+ sciatic nerves, most fibers remained unmy-
elinated; the few myelin sheaths present were abnormally thin
(Fig. 1). Most Dicer-depleted Schwann cells properly sorted
axons, resulting in the typical 1:1 Schwann cell to axon ratio.
However, some bundles of Dicer mutant nerves containing axons
.1mm, which would normally be sorted and myelinated,
remained unsorted (Fig. 1c and 1f).
We did not observe normal Remak bundle formation in Dicer
mutant nerves. Small-caliber axons remained in groups that also
contained large caliber axons. In contrast to normal Remak
bundle formation [16], groups of small-caliber axons and were
engulfed by Schwann cells as a whole, and axons were not
individually ensheathed and separated from each other by
Schwann cell processes (mesaxons). In addition, the number of
these immature axon bundles was far lower than the number of
Remak bundles in control nerves, indicating that unmyelinated
nerve fiber development was also severely disturbed in these
nerves. To determine at which stage myelin development was
blocked in Dicerfl/fl Dhh-Cre+ mice, we compared myelin markers
between Dicerfl/fl Dhh-Cre+ and Dicerwt/fl Dhh-Cre+ nerves with
immunohistochemical and biochemical techniques (Fig. 2). Com-
ponents of mature non-compact myelin like 29,39- cyclic
nucleotide 39-phosphodiesterase (CNPase), and of compact
myelin, like myelin basic protein (MBP) and peripheral myelin
protein 22 (PMP22), were nearly undetectable in Dicerfl/fl Dhh-
Cre+ nerves via immunoblot (Fig. 2d).
Figure 1. Defective myelination following Schwann cell specific Dicer depletion. Electron microscopy of sciatic nerves derived from 18-day
old Dicerfl/fl Dhh-Cre+ (C and F) and control Dicerwt/fl Dhh-Cre+ (B and E) and Dicerfl/fl Dhh-Cre2 (A and D) littermates. Low magnification figures
(A–C) show normally myelinated nerves fibers in control mice (A and B) and normal Remak bundles of unmyelinated small-caliber axons (black
stars). In Dicer depleted mice (C), most of the large caliber axons remain unmyelinated; only a few fibers are ensheathed by a thin myelin sheath
(black arrowheads). Most of these nerve fibers show proper axonal sorting by Schwann cells; only a few large-caliber axons remain unsorted (white
arrowheads). Higher magnification figures show normal myelinated and unmyelinated nerve fibers (D and E) in controls. A Schwann cell in Dicerfl/fl
Dhh-Cre+ mice containing non-sorted and unmyelinated large caliber axons is shown. Basal lamina formation by this Schwann cell is evident (black
arrow), indicating development into immature Schwann cell (F). Scale bar in A–C= 10 mm and in D–F= 1 mm.
doi:10.1371/journal.pone.0012450.g001
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Schwann cells were not absent in Dicerfl/fl Dhh-Cre+ nerves, as
evidenced by EM and by positive S100 immunoreactivity in
nerves of 22-day old mice (Fig. 2a). Furthermore, EM analysis of
Schwann cells in Dicer mutant nerves showed basal lamina
formation by Schwann cells (Fig. 1f). These findings indicate that
Schwann cells in Dicer mutant nerves developed at least until the
stage of immature Schwann cells. Proper sorting of the majority of
axons suggested an arrest at the pro-myelin stage. Development of
myelinating Schwann cells is known to be accompanied by
cessation of Schwann cell proliferation. In contrast to Dicerwt/fl
Dhh-Cre+ nerves, Dicer mutant nerves showed evidence of mitotic
events and a significantly increased percentage of Schwann cells
expressing proliferation marker MIB1 (Ki67; 11.860.9% in Dicer
mutant Schwann cells versus 1.2260.07% in controls, p=0.0003;
Fig. 2b). Based on immunohistochemistry, we determined that
sciatic nerves of Dicer mutant mice contained no B-cells (B220)
and only rare T-cells (CD3; 1.660.6% positive cells per total
number of nuclei in Dicerfl/fl Dhh-Cre+ nerves versus 1.660.2%
in controls, p=0.96, Fig. 2c). An increased prevalence of
macrophages was detected in Dicer mutant nerves (CD68;
11.363.5% positive cells per total number of nuclei in Dicerfl/fl
Dhh-Cre+ nerves versus 7.262.4% in controls, p=0.04, Fig. 2c).
Although we observed an increased number of macrophages in
Dicer mutant nerves, the percentage was in a similar range in
Dicer mutant and controls. Based on this and based on their
morphology with elongated nuclei, we conclude that the
proliferating cells were indeed Schwann cells. In parallel to
increased proliferation, Dicer mutant nerves at p22 showed
increased cell death as determined by TUNEL staining
(,0.05% TUNEL positive nuclei in all control nerves and ca.
2% in Dicer mutant nerves). Erk and Akt signal transduction
pathways which are known to regulate myelination were
significantly altered in 18-day old mutant nerves. Both Akt and
Erk phosphorylation were significantly increased. Furthermore,
Ras and NFkB protein expression was significantly lower in Dicer
mutant nerves compared to controls (Fig. 2d).
Figure 2. Histological and biochemical analysis of mice lacking Dicer in Schwann cells. (A–C) Longitudinal sections of sciatic nerves from
22-day old Dicerfl/fl Dhh-Cre+ and control Dicerwt/fl Dhh-Cre+ littermates stained with haematoxylin and eosin (HE) or decorated with S100, MIB1, CD3,
or CD68 antibody. At least four nerves were analyzed per genotype. Scale bars = 50 mm. S100 positivity indicates Schwann cell development
progresses at least up to the stage of immature Schwann cells (A). Increased proliferation in Dicer mutant nerves, as indicated by mitotic events
(black arrows in A) and increased percentage of positive nuclei in MIB1 immunohistochemistry (B). Quantification of MIB1-positive nuclei shows a
significantly higher percentage of proliferating cells in Dicerfl/fl Dhh-Cre+ compared to Dicerwt/fl Dhh-Cre+ littermate nerves. Error bars indicate
standard deviation, p= 0.0003, p value was determined using unpaired two-tailed student’s t-test (B). Few CD3-positive T cells and an increased
percentage of CD68-positive macrophages infiltrated the nerves of Dicerfl/fl Dhh-Cre+ mice (C). Biochemical analysis of signal transduction pathways
and myelin components by Western blot (D). Compared to control Dicerwt/fl Dhh-Cre+ littermates, phospho-Akt and phospho-Erk were significantly
increased in sciatic nerves of 18-day old mice lacking Dicer in Schwann cells, while total Akt and Erk protein levels were unchanged compared to
controls, and NFkB was significantly decreased. In agreement with the histological findings, components of non-compact (CNPase) and compact
myelin (MBP, PMP22) were nearly absent from Dicer mutant nerves. In addition, Ras levels were significantly lower in Dicer mutant nerves. GAPDH
and b-actin served as loading controls.
doi:10.1371/journal.pone.0012450.g002
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Next, we performed a time course analysis of changes in Dicer
mutant nerves (Fig. 3). At four days of age (p4), EM analysis of
sciatic nerves showed myelin formation in control Dicerwt/fl Dhh-
Cre+. In contrast, no myelinating Schwann cells were observed in
Dicer mutant nerves of age-matched Dicerfl/fl Dhh-Cre+ litter-
mates. As in the 18-day old mice, proper radial sorting with 1:1
Schwann cell-to-axon ratio was observed in most fibers at p4
(Fig. 3a). In contrast, EM analysis of sciatic nerves from Dicerfl/fl
Dhh-Cre+ versus Dicerwt/fl Dhh-Cre+ mice at the age of 17
embryonic days (E17) revealed no structural difference (Fig. 3a).
Dicer expression is upregulated upon myelination in control p4
nerves compared to control E17 nerves. In Dicerfl/fl Dhh-Cre+ at
E17 and at p4, Dicer depletion was found by quantitative RT-
PCR (Fig. 3e). Furthermore, presence of the inactivated Dicerflox
allele was shown by PCR (Fig. 3f).
The expression of specific miRNAs is altered in
Dicer-deficient peripheral nerves
To identify specific miRNAs involved in peripheral nerve
myelination, we performed a differential microarray analysis of
miRNA extracted from Dicerfl/fl Dhh-Cre+ and Dicerwt/fl Dhh-
Cre+ nerves. Since the Dhh promoter is specifically active in
Figure 3. Time course analysis of defective myelination following Schwann cell specific Dicer depletion. Sciatic nerves of embryos (E17)
and newborn mice (p4) were analyzed by electron microscopy for morphological effects of Schwann cell-specific Dicer depletion (A), and by
quantitative RT-PCR for mRNA expression of factors known to regulate myelination. Number of biological replicates used: Dicerfl/fl Dhh-Cre+ E17 n= 4,
Dicerwt/fl Dhh-Cre+ E17 n= 3, Dicerfl/fl Dhh-Cre+ p4 n= 4, and Dicerwt/fl Dhh-Cre+ p4 n=4 (B–D). No morphological difference was observed before the
onset of myelination at E17 between Dicerwt/fl Dhh-Cre+ and Dicerfl/fl Dhh-Cre+ nerves. By p4, myelination had begun in Dicerwt/fl Dhh-Cre+ mice, but
not in Dicerfl/fl Dhh-Cre+ nerves. Some unsorted fibers were visible in Dicerfl/fl Dhh-Cre+ nerves. Scale bars = 2 mm (A). Quantitative RT-PCR for mRNA
expression in Dicer mutant nerves showed lack of developmental upregulation for activators of myelination. P values for comparisons between p4
controls and mutants were: p= 0.0026 (Oct6), p=0.0028 (Egr2), p=0.0003 (Brn2), p= 0.0028 (Sox10; B), no significant difference in expression of
suppressors of myelination Sox2 and c-jun (C) and altered expression of Notch signaling components and p75NTR. P values for comparisons between
p4 controls and mutants were: p=0.061 (Delta1), p=0.043 (Jagged1), p= 0.0001 (Jagged2), p=0.02 (Notch3), p= 0.0061 (p75NTR; D). Dicer mRNA
expression was significantly upregulated upon myelination in Dicerwt/fl Dhh-Cre+ sciatic nerves (p4 in comparison with E17, p= 0.0004). At both time
points, E17 and p4, significant Dicer mRNA depletion in Dicerfl/fl Dhh-Cre+ was shown (E17: p= 0.0007; p4: p,0.0001; E). Presence of the recombined
Dicer allele in E17 and p4 mice was demonstrated by PCR using primers that differentiate between wild type Dicer and the recombined allele (F). The
wild type allele is 1.3 kb in length, and the recombined allele is approx. 500bp (G). Akt phosphorylation and expression were analyzed by Western
blot in Dicerwt/fl Dhh-Cre+ compared to Dicerfl/fl Dhh-Cre+ at p4. P-Akt in relation to total Akt was reduced to 62614% of control level in Dicerfl/fl Dhh-
Cre+ at p4. All p values were determined using an unpaired two-tailed student’s t-test. All error bars indicate standard deviation.
doi:10.1371/journal.pone.0012450.g003
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Schwann cells, we would expect Dicer to be ablated exclusively in
this cell type (not neurons or other cell types in the analyzed nerve)
and the microarray to identify miRNAs specifically expressed in
Schwann cells. We chose two different developmental time points
for analysis. The first time point was before the onset of
myelination and before structural differences could be observed
between Dicerfl/fl Dhh-Cre+ and Dicerwt/fl Dhh-Cre+ nerves (at
E17). The second time point was p4, when myelination had
already started in control mice and was already evidently impaired
in Dicerfl/fl Dhh-Cre+ mice.
Among the 216 miRNAs expressed in peripheral nerves, we
identified a total of 109 miRNAs which were either significantly
developmentally up- or downregulated (p4 compared to E17) or
significantly different between controls and mutants (Fig. 4). For
the observed phenotype, however, the miRNAs of major interest
were those which displayed an upregulation upon the onset of
myelination and were also significantly downregulated in p4 Dicer
mutant nerves compared to controls. The sixteen miRNAs which
fulfilled these two criteria mentioned above are listed (Table 1).
For nine of these miRNA we could confirm the differential
expression by real time PCR using miRNA specific Taqman
probes (Fig. 5). Since downregulation of Schwann cell miRNAs
might also control important steps of proper myelination, we
analyzed the microarray dataset for those miRNAs that were
significantly downregulated upon myelination and significantly
reduced by ablation of Dicer from Schwann cells (either at E17 or
at p4). Only three microRNAs met these criteria: miR-9, miR-
455, and miR-1224.
Altered myelination signals in Dicer-deficient peripheral
nerves
In order to determine the effect of miRNA depletion from
Schwann cells on the expression of molecules involved in
peripheral nerve myelination, we performed quantitative RT-
PCR on mRNA isolated from E17 and p4 Dicerfl/fl Dhh-Cre+ and
Dicerwt/fl Dhh-Cre+ nerves. The mRNA expression of several
transcription factors, cell surface receptors, and other molecules
known to be involved in peripheral nerve myelination was
significantly altered in p4 Dicerfl/fl Dhh-Cre+ nerves compared
to Dicerwt/fl Dhh-Cre+ (Fig 3b–d). The factors known to promote
myelination, Oct6, Egr2, Brn2, and Sox10, were all significantly
downregulated in Dicer mutant nerves. Apart from Brn2, dicerless
nerves from 4-day old mice expressed these factors at levels similar
to embryonic nerves from E17 mice (Fig. 3b). Inhibitors of
myelination, including Sox2 and c-Jun were not altered (Fig. 3c).
We also observed dysregulation of components of the Notch
signaling pathway, including significant downregulation of Notch3
and Jagged2, as well as a somewhat lower Delta1 expression
(which did not attain statistical significance) in Dicer mutant
nerves. In contrast, Jagged1 was upregulated in Dicer mutant
nerves. Therefore, loss of miRNA expression in peripheral nerves
dramatically alters the balance between pro- and anti-myelin
signals.
Discussion
Here we show that Dicer expression in developing Schwann
cells is crucially involved in peripheral myelination. By using a
different, independently generated conditional Dicer knockout
mouse strain [17,18], we confirm recently published data [14].
The morphological and ultrastructural changes in dicerless
peripheral nerves points to a crucial role for miRNAs in the
transition of Schwann cells from the pro-myelin stage to the
myelinating stage. Although Dicer is depleted at earlier develop-
mental stages in Schwann cell precursors of Dicerfl/fl Dhh-Cre+
mice, Dicer-deficient Schwann cells are nevertheless able to reach
the immature Schwann cell stage, as evidenced by positive S100
expression and basal lamina formation in Dicerfl/fl Dhh-Cre+
nerves and despite an altered microRNA expression profile
already evident at E17. Proper sorting of the majority of axons
indicate that Schwann cell differentiation into the myelinating
phenotype is mainly arrested at the pro-myelin stage at the time
when Dicer expression begins to increase in control sciatic nerves
(Fig. 6). The reduction in mature myelin by ultrastructural or
biochemical analysis (CNPase, MBP, PMP22) supports this
conclusion. Some fibers appeared to overcome the myelination
block, possibly due to incomplete recombination or due to the
presence of residual Dicer protein that persists after genetic
ablation. However, the myelin sheaths formed around these nerves
are abnormally thin, confirming previous findings [14]. Dicer-
deficient Schwann cells not only failed to myelinate, but also were
unable to form normal Remak bundles of unmyelinated small-
caliber axons. Cre expression itself has been shown to be toxic to
certain cell types [19]. To exclude that toxicity of Cre expression
in Schwann cells induced myelination defects or miRNA
expression changes, we used Dicerwt/fl Dhh-Cre+ littermates as
controls. We did not see any evidence for spurious effects on
myelination due to Cre expression.
Myelin formation is known to be associated with cessation of
Schwann cell proliferation. In 22-day old Dicerfl/fl Dhh-Cre+
nerves, we observed mitotic events within Schwann cell nuclei and
an increased proliferation rate as determined by Ki67 staining.
The increased cell proliferation observed in arrested immature
Schwann cells was not seen by others, as determined by BrdU
incorporation rates in younger mice only [14]. This difference may
reflect the age difference of the analyzed mice. In contrast to the
result of the previous study, our data suggests that increased
Schwann cell proliferation is indeed a consequence of Dicer
ablation from Schwann cells and accompanies the defect in
myelination, at least at an older age. Consistently with Pereira et
al., we also observed a slight increase in the number of TUNEL-
positive cells in sciatic nerves of Dicer mutant mice.
How can the above findings be mechanistically explained? In
Dicer-less Schwann cells, a global reduction of all miRNAs may
directly lead to both Schwann cell proliferation and death, maybe
because certain miRNAs are necessary for exiting the cell cycle,
terminal differentiation, and cell survival (Fig. 6). It is not
necessarily contradictory that both cell death and cell proliferation
are stimulated in the absence of Dicer, since its global effect on all
miRNAs is expected to produce pleiotropic phenotypes. Alterna-
tively, in the absence of Dicer, arrested pro-myelin Schwann cells
may become prone to degeneration. Cell death might induce
compensatory proliferation, either of Schwann cells lacking Dicer
or of Schwann cells in which recombination of the Dicerflox allele
has failed. However, it is not obvious which signalling pathway
might trigger such a hypothetical compensation. Also, the lower
percentage of dying cells (2%) compared to the higher percentage
of proliferating cells (11%) argues against compensatory prolifer-
ation.
By microRNA microarray, we identified numerous miRNAs
that are expressed in peripheral nerves during development at E17
and p4. Among the 216 expressed miRNA, 109 were either up- or
downregulated upon differentiation of immature Schwann cells at
E17 into myelinating Schwann cells at p4, or differentially
expressed as a consequence of Dicer depletion at E17 or at p4.
Unexpectedly, for a number of miRNAs, Dicer mutant Dicerfl/fl
Dhh-Cre+ nerves showed a higher expression when compared to
control Dicerwt/fl Dhh-Cre+ nerves. This suggests that other
miRNAs in Myelination
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endoneural cells like fibroblast and endothelial cells or axonally
transported miRNAs may contribute to the overall pool of
miRNAs which are regulated in response to Schwann cell-specific
lack of miRNA expression.
It is plausible to assume that miRNAs crucially involved in
myelination should be upregulated as Schwann cell development
progresses towards the myelinating phenotype. We therefore
selected those miRNAs that were both (1) significantly upregulated
upon myelination and (2) significantly decreased upon Dicer
depletion in Schwann cells. Only 16 miRNAs met these criteria
(Table 1). Furthermore, we identified miR-9, miR-455, and miR-
1224 as microRNAs downregulated upon myelination and
reduced following Dicer ablation from Schwann cells. MiR-9
has previously been shown to regulate PMP22 expression in
oligodendrocytes [13]. Assuming that PMP22 is also regulated by
miR-9 in Schwann cells, the downregulation of this negative
Figure 4. Heat map of developmentally and/or Dicer dependently regulated miRNAs in sciatic nerves. Expression of miRNAs in sciatic
nerves of E17 and p4 Dicerfl/fl Dhh-Cre+ and control Dicerwt/fl Dhh-Cre+ littermates was analyzed by miRNA microarray. Four biological replicates for
each group were analyzed on separate arrays. Of the 216 miRNAs expressed, 109 miRNAs (listed on the right side of the heat map) were differentially
expressed, either in an age-dependent manner or in a manner dependent on the expression of Dicer in Schwann cells (p#0.05, log2 ratio$0.5).
Differential expression in log2 ratio is color coded as indicated in the legend below the heat map (red= upregulation, green=downregulation). Based
on hierarchical clustering, five groups, each containing miRNAs of similar expression pattern are indicated by gray bars on the left side. Group 1
contains miRNAs which are upregulated in Dicerfl/fl Dhh-Cre+ compared to Dicerwt/fl Dhh-Cre+ nerves at E17 and at p4. Group 2 contains miRNAs that
are downregulated in both genotypes at p4 compared to E17. Group 3 includes miRNAs that are downregulated in Dicerwt/fl Dhh-Cre+ nerves at p4
when compared to E17 and downregualted in Dicerfl/fl Dhh-Cre+ compared to Dicerwt/fl Dhh-Cre+ nerves at E17. Group 4 contains miRNAs which are
downregulated in Dicerfl/fl Dhh-Cre+ compared to Dicerwt/fl Dhh-Cre+ nerves at p4 and are abundantly expressed also in Dicerwt/fl Dhh-Cre+ nerves at
E17. Group 5 includes miRNAs that are upregulated in Dicerwt/fl Dhh-Cre+ nerves at p4 compared to both, Dicerfl/fl Dhh-Cre+ and Dicerwt/fl Dhh-Cre+
nerves at E17.
doi:10.1371/journal.pone.0012450.g004
Table 1. miRNAs significantly upregulated in sciatic nerves during myelination log2 ratio $0.5 and significantly decreased as a
consequence of Schwann cell specific Dicer depletion log2 ratio #20.5.
Agilent
Systematic
name
effect of Schwann cell specific
Dicer depletion in P4
[pValue]
effect of Schwann cell specific
Dicer depletion in P4
[log2 Ratio]
myelination effect in
Dicer +/2 Dhh-Cre+
[pValue]
myelination effect in
Dicer +/2 Dhh-Cre+
[log2 Ratio]
mmu-miR-338-3p 0.0000024 23.01 0.00087 0.96
mmu-miR-338-3p 0.000010 22.15 0.00067 1.05
mmu-miR-34a 0.00000046 22.31 0.0000039 1.55
mmu-miR-34a 0.00000041 22.20 0.0000061 1.52
mmu-miR-204 0.000010 22.28 0.0025 1.11
mmu-miR-204 0.000010 21.55 0.0011 0.92
mmu-miR-146b 0.00000031 22.25 0.00000023 2.14
mmu-miR-146b 0.000020 20.69 0.0000071 0.70
mmu-miR-27b 0.0000040 21.55 0.00019 0.97
mmu-miR-27b 0.000074 21.00 0.00025 0.71
mmu-miR-30a 0.000024 21.35 0.00015 1.05
mmu-miR-30a 0.000026 21.23 0.00016 0.98
mmu-miR-30a 0.000090 20.98 0.023 0.64
mmu-miR-140 0.000035 21.07 0.00015 0.83
mmu-miR-140 0.0000035 20.81 0.0000089 0.65
mmu-miR-23b 0.000092 21.00 0.0019 0.55
mmu-miR-23b 0.00018 20.98 0.0036 0.80
mmu-miR-138 0.0000038 20.90 0.000017 1.01
mmu-miR-138 0.000069 20.69 0.000091 0.74
mmu-miR-30a* 0.000027 20.88 0.00021 0.61
mmu-miR-100 0.00048 20.84 0.000047 0.92
mmu-miR-100 0.00039 20.57 0.000075 0.95
mmu-miR-140* 0.00089 20.78 0.00073 0.69
mmu-miR-30c 0.00044 20.77 0.000044 0.79
mmu-miR-30b 0.00080 20.77 0.00088 0.75
mmu-miR-24 0.00017 20.72 0.00039 0.54
mmu-miR-24 0.000048 20.67 0.0014 0.67
mmu-miR-195 0.0000083 20.57 0.00000067 1.31
doi:10.1371/journal.pone.0012450.t001
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regulator of the major myelin protein PMP22 upon myelination
should promote myelin formation.
Although downregulation of miRNAs might also be crucial
during the development of peripheral myelin, such miRNAs are
unlikely to be responsible for the observed phenotype following
Dicer depletion in our study.
Some of the upregulated miRNAs are important for oligoden-
drocyte differentiation, e.g. miR-338 [11,12] and miR-138 [11]. In
addition, developmental upregulation of some miRNAs identified
in our screen was observed in differentiating oligodendrocytes in
vitro, including miR-146, miR-23b, miR-24, and miR-27b in one
study [13] and miR-204, miR-27b and miR-100 very recently in
another study [20]. However, some miRNAs identified have not
been previously reported to be involved in myelination, including
miR-195, miR-140, miR-34a, miR-30a, miR-30b, miR-30c, and
miR-140*. Interestingly, miR-219, despite being independently
identified by two different groups as a key regulator of
oligodendrocyte differentiation and CNS myelination [11,12],
was not identified as being differentially expressed in Dicerfl/fl
Dhh-Cre+ peripheral nerves in our miRNA screen.
Another study analyzed and compared the miRNA expression
pattern in proliferating and differentiated rat Schwann cells in vitro
[21]. This study focused on downregulation of rno-miRNA-29a
expression in differentiated Schwann cells and the negative
regulatory effect of miRNA-29a on PMP22 expression. In our
study, miRNA-29a was slightly but not significantly upregulated
upon myelination, indicating that its inhibitory effect on PMP22
expression plays no major role in mice in vivo at this time point of
development. The miRNAs identified by Verrier et al. to be
upregulated in differentiated Schwann cells showed no overlap
with our main candidates in vivo [21]. This is most likely caused by
the differences in the experimental design. Under specific
conditions, e.g. in nerve regeneration or at later time points of
development, other miRNAs might be involved.
The process of myelination requires the specific upregulation of
pro-myelinating proteins and the coordinated downregulation of
anti-myelinating proteins at specific stages of myelin maturation.
Interestingly, we found that several transcripts (Oct6, Egr2, Brn2,
Sox10) encoding pro-myelinating proteins fail to be upregulated in
Dicerfl/fl Dhh-Cre+ nerves, with expression levels of Oct6, Egr2,
and Sox10 in Dicerfl/fl Dhh-Cre+ p4 nerves closely matching those
in Dicerwt/fl Dhh-Cre+ E17 nerves. The only exception was Brn2,
which was further downregulated in Dicerfl/fl Dhh-Cre+ p4 nerves
than in E17 nerves. This is in contrast to the recent study by
Pereira et al., where Sox10 expression was not significantly
reduced and Oct6 expression was only marginally reduced. The
dramatic downregulation of Egr2 reported by Pereira et al., on the
other hand, was consistent with our study [14]. In addition, we
found elevated levels of p75NTR mRNA in Dicerfl/fl Dhh-Cre+
nerves, which is normally down-regulated after onset of myelina-
tion.
miRNA expression is normally associated with silencing of
target mRNAs, either through enhanced mRNA degradation or
translational inhibition of target transcripts. Therefore the Sch-
wann cell differentiation defect observed in nerves of Dicerfl/fl
Dhh-Cre+ mice might reflect the failure of Dicerfl/fl Dhh-Cre+
Schwann cells to downregulate anti-myelin signaling molecules.
We tested the mRNA expression of the anti-myelinating factors
Sox2 and c-Jun in Dicerfl/fl Dhh-Cre+ versus Dicerwt/fl Dhh-Cre+
nerves. We did not detect any significant difference in Sox2 or c-
Jun mRNA expression between these two groups at the mRNA
level; however, Pereira et al. reported elevated Sox2 in Dicerfl/fl
Dhh-Cre+ nerves [14].
miRNA-34a was recently shown to act as a tumor suppressor in
human glioma cells by inhibiting cell proliferation [22,23]. It has
recently been shown that miRNA-34a is also downregulated in
tumors of peripheral nerves called malignant peripheral nerve
sheath tumors (MPNST) where it may act as a tumor suppressor as
well [24]. MiRNA-34a was a main candidate in our screen and a
major histological observation in Dicer mutant nerves was an
increased Schwann cell proliferation. It is likely that miRNA-34a
drives Schwann cell differentiation by shutting down their
proliferation during development; failure of this regulatory circuit
may be involved in the histogenesis of schwannomas. Besides miR-
Figure 5. Real time PCR confirmation of miRNAs upregulated upon myelination. Expression of miRNAs in sciatic nerves of E17 and p4
Dicerfl/fl Dhh-Cre+ (fl/fl) and control Dicerwt/fl Dhh-Cre+ (wt/fl) mice was analyzed by real time PCR with Taqman probes. The levels of miRNA
expression were quantified in comparison with sno234 RNA as the endogenous control. Expression is shown as relative values compared to p4
Dicerwt/fl Dhh-Cre+. Error bars indicate standard deviation. All miRNAs analyzed were significantly downregulated in Dicerfl/fl Dhh-Cre+ nerves at p4:
p#0.0001 (miR-34a, miR-146b, miR-338-3p, miR-204, miR-27b, miR-140, miR-138, miR-30a), p= 0.0002 (miR-195). Furthermore, miRNAs were
confirmed to be upregulated upon myelination: p#0.0001 (miR-34a, miR-146b), p= 0.04 (miR-338-3p), p=0.003 (miR-204), p= 0.0007 (miR-27b),
p= 0.005 (miR-140), p= 0.0002 (miR-138), p= 0.01 (miR-195), p=0.0004 (miR-30a). P values were determined using unpaired two-tailed student’s t-
test.
doi:10.1371/journal.pone.0012450.g005
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34a, other miRNAs that were identified in our screen were
previously found to be associated with an inhibitory effect on
proliferation of non-neural tumor cells, including miR-24 in HeLa
cells [25] and miR-100 in oral squamous cell carcinoma [26].
Furthermore, we observed an increased phosphorylation of Erk
in Dicer mutant nerves at p20. Activation of the Erk pathway is
known to induce dedifferentiation of Schwann cells and Schwann
cell proliferation, and might contribute to the observed failure of
Schwann cells to myelinate [27,28]. Also, overexpression of Ras
protein can induce Schwann cell differentiation and proliferation
arrest, in contrast to its proliferation-promoting effects on other
cell types [29,30]. In Dicer mutant nerves, we observed a
significantly lower Ras expression compared to control nerves.
Therefore, low levels of Ras might also contribute to the observed
phenotype.
We also found altered mRNA expression of transcripts involved
in Notch signaling, including Jagged1, Jagged2, and Notch3. In
addition, Pereira et al. observed an increased expression of Notch1,
and Hes1, as well as a reduced level of ErbB2 in Dicerfl/fl Dhh-Cre+
nerves [14]. Of note, Jagged1 and Notch1 which were upregulated
at the mRNA level in Dicerfl/fl Dhh-Cre+ nerves compared to
Dicerfl/fl Dhh-Cre+, were previously identified as a target of miR-
34a, which we identified in our miRNA screen [22,31]. Deregulated
Notch and/or neuregulin signaling may therefore partly explain the
failure of immature Schwann cells to upregulate some pro-myelin
transcripts, such as Egr2. Consistently with Pereira et al. we
observed impaired Akt phosphorylation at Ser-473 in Dicer mutant
nerves at the onset of myelination (at p4/p5) [14]. In contrast, at
p18 we observed increased Akt phosphorylation in Dicer mutant
nerves. Hence in young mice deletion of Dicer led to a reduction of
the pro-myelinating phosphorylation of Akt. Since Akt activation
promotes myelination [32], increased Akt phosphorylation may
reflect a compensatory upregulation of pro-myelinating signals in
response to abnormally high levels of anti-myelinating factors in the
absence of miRNA regulation at an older age. In any case, it seems
as if the compensatory response in Dicerfl/fl Dhh-Cre+ nerves is
unable to override anti-myelination signals, as the nerves neverthe-
less fail to myelinate.
It will be interesting to determine in the future whether miRNAs
that are upregulated in both CNS and PNS myelination play
analogous roles and/or target the same proteins in these cell types.
Conversely, miRNAs that are distinctly upregulated in either
oligodendrocytes or Schwann cells may target proteins and/or
control processes that are specific to either PNS or CNS
myelination.
Clearly, miRNAs play a crucial role in the myelination process
both in the CNS and the PNS. An important task that remains for
future studies will be to positively identify Schwann cell-specific
target transcripts of and the mode of regulation by miRNAs that
are specifically upregulated in peripheral nerves during PNS
myelination.
Materials and Methods
Mice and ethical statement
We housed mice and performed animal experiments in
accordance with the Swiss Animal Protection Law and in
compliance with the animal welfare regulations of the Canton of
Zurich. The Committee on Animal Experimentation of the
Cantonal Veterinary Office of the Canton of Zurich has
specifically approved this study under license number 200/2007.
Dicerfl/fl mice were obtained from Jackson Laboratory (strain
name: Dicer1tm1Bdh/J; stock number: 006001) [17]. Dhh-Cre mice
were kindly provided by Dr. Dies Meijer [33]. Dicerfl/fl mice were
crossed to Dhh-Cre, and subsequently, F1 mice were bred again to
Dicerfl/fl mice to obtain Dicerfl/fl Dhh-Cre+ mice. For identifying
Dhh-Cre transgene positive mice, the following primers were used:
Cre fw: ACC CTG TTA CGT ATA GCC GA, Cre rev: CTC
CGG TAT TGA AAC TCC AG. For distinguishing Dicer floxed
and Dicer wild-type alleles, the following primers were used: DF1:
CCT GAC AGT GAC GGT CCA AAG and DR1: CAT GAC
TCT TCA ACT CAA ACT, producing a wild-type allele-specific
product of 350bp and a floxed allele-specific product of 420bp.
The recombined allele was amplified using DF1 primer and Ddel
primer: CCT GAG CAA GGC AAG TCA TTC, the same primer
set recognized also the wild-type allele (product size 1.3 kb).
Figure 6. The role of Dicer and miRNAs in Schwann cell development. In the absence of Dicer, Schwann cells develop normally to the pro-
myelin stage with properly sorted axons (light yellow). The presence of Dicer is required for acquisition of myelination competence by Schwann cells
(turquoise). When Dicer is removed from Schwann cells (red), reduction of miRNAs leads to Schwann cell hyperproliferation and degeneration,
suggesting that miRNAs are essential both for driving maturing Schwann cells into cell cycle arrest and terminal differentiation, as well as for their
survival.
doi:10.1371/journal.pone.0012450.g006
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Electron microscopy
Mice at the age of p4 or older were anesthetized and
transcardially perfused with PBS followed by 3.9% glutaraldehyde
in 0.1 M phosphate buffer, pH 7.4. Sciatic nerves of embryos
(E17) were fixed with glutaraldehyde in situ for at least 5 minutes.
At least n = 4 mice of each genotype and age group (E17, p4, and
p18, mixed gender) were analyzed. All nerves were then postfixed
in glutaraldehyde in a test tube. Tissues were embedded in Epon
using standard procedures. Semithin sections were stained with
toluidine blue. Ultrathin sections were mounted on copper grids
coated with Formvar membrane and contrasted with uranyl
acetate/lead citrate. We examined the specimens using a Hitachi
H-7650 transmission electron microscope operating at 80 kV. We
took pictures with a digital CCD camera.
miRNA microarray
miRNA was extracted from sciatic nerves as described in the
next section. Sciatic nerves of embryos at the gestational age of 17
days (E17) or newborns at the age of 4 days (p4) were used. For
each time point, 4 pairs of Dicerfl/fl Dhh-Cre+ littermates and
Dicerwt/fl Dhh-Cre+ were used and analyzed separately on
individual arrays (Dicerfl/fl Dhh-Cre+ E17 n= 4: 1 male, 3
females, Dicer+/fl Dhh-Cre+ E17 n=4: 1 male, 3 females,
Dicerfl/fl Dhh-Cre+ p4 n= 4: 1 male, 3 females, and Dicer+/fl
Dhh-Cre+ p4 n=4: 2 males, 2 females). Purity and quality of the
isolated total RNA was determined using a NanoDrop ND 1000
(NanoDrop Technologies) and a Bioanalyzer 2100 (Agilent)
respectively. Only those samples with a 260 nm/280 nm ratio
between 1.6–2.1 and a 28S/18S ratio within 1.5–2 were further
processed. Fluorescent miRNA with a sample input of 100ng of
total RNA was generated. This method involves the ligation of one
Cyanine 3-pCp molecule to the 39 end of an RNA molecule using
a miRNA Complete Labeling and Hyb Kit (Agilent). The quality
of Cy3- RNA was determined using a NanoDrop ND 1000. Only
RNA samples with a dye incorporation rate .2 pmol/mg were
considered for hybridization. Cy3-labeled RNA samples were
mixed with an Agilent Blocking Solution and resuspended in
Hybridization Buffer using a miRNA Complete Labeling and Hyb
Kit (Agilent). Target RNA Samples (45ml) were hybridized to
Mouse miRNA 8x15k OligoMicroarrays (Agilent P/N G4472A,
Design ID 019119y) for 20h at 55uC. Arrays were then washed
using Agilent GE Wash Buffers 1 and 2 (Agilent), according to the
manufacturer’s instructions. An Agilent Microarray Scanner
(Agilent p/n G2565BA) was used to measure the fluorescent
intensity emitted by the labeled target. Raw data processing was
performed using the Agilent Scan Control and the Agilent Feature
Extraction Software Version 10.5.1.1. Quality control measures
were considered before performing the statistical analysis. These
included inspection of the array hybridization pattern (absence of
scratches, bubbles, areas of non hybridization), proper grid
alignment and number of green feature non-uniformity outliers
(below 100 for all samples). Expression data was analyzed using R/
Bioconductor. Briefly, median spot signals were log2-transformed
and normalized using quantile normalization. Differential expres-
sion was assessed using t-test and fold-change analysis. miRNAs
flagged as absent by the Feature Extraction Software in more than
50% of the samples in each of the 4 conditions were excluded from
the results. All data is MIAME compliant and the raw data is
available in the GEO archive under the accession GSE22023. For
hierarchical clustering of the heatmap, we used as distance
measure the euklidean distance of the normalized expression
profiles of the miRNAs. Clusters were linked using the Ward’s
linkage rule that minimizes intra-cluster variance. A simplified
version of the clustering tree is visualized on the left side of the heat
map, including five groups of miRNAs.
RNA extraction and real time PCR
RNA was extracted from sciatic nerves using miRNeasy
(Qiagen) as described by the manufacturer using a polytron PT
3100 (kinematica). CDNA from mRNA was synthesized with
QuantiTect, Reverse Transcription kit (Qiagen) and analyzed by
real-time PCR using QuantiFast SYBR Green PCR kit (Qiagen).
CDNA from miRNA was synthesized with TaqMan MicroRNA
RT kit (Applied Biosystems) and analyzed using TaqMan
MicroRNA Assays (Applied Biosystems) and Taqman Universal
Master Mix II (Applied Biosystems). All samples were analyzed
using a 7900HT Fast Real-Time PCR system (Applied Biosys-
tems). Three to four biological replicates were used for each group
analyzed (Dicerfl/fl Dhh-Cre+ E17 n= 4: 3 males, 1 female,
Dicer+/fl Dhh-Cre+ E17 n=3: 3 males, Dicerfl/fl Dhh-Cre+ p4
n=4: 3 males, 1 female, and Dicer+/fl Dhh-Cre+ p4 n= 4: 2 males,
2 females). Of each biological replicate, two (mRNA) or three
(miRNA) technical replicates were performed. The following
primers were used: c-jun fw: CCT TCT ACG ACG ATG CCC
TC, c-jun rev: GGT TCA AGG TCA TGC TCT GTT T; Notch3
fw: CCA TCC TTG GAC TCA GGC, Notch3 rev: AGC TGG
TGT TAG TAG CTC C; Jagged1 fw: GTT CTC CAA ATA ACT
GTT CCC, Jagged1 rev: ATT TCA TTC TGA CAG TGA CCC;
Jagged2 fw: TGC TGT CTG GCT TTG AAT GCC, Jagged2 rev:
AGC ATT AAG GCA CGG TTT CCC; Delta1 fw: TTG TTC
TTT CTC AGT GCC TCG, Delta1 rev: CCC TTC TTG TTG
ACG AAC TCC; Sox2 fw: GCG GAG TGG AAA CTT TTG
TCC, Sox2 rev: CGGGAAGCGTGTACTTATCCTT; Oct6 fw:
TCG AGG TGG GTG TCA AAG G, Oct6 rev: GGC GCA TAA
ACG TCG TCC A, Egr2 fw: AAT GGC TTG GGA CTG ACT
TG, Egr2 rev: GCC AGA GAA ACC TCC ATT CA; Sox10 fw:
AGA TGG GAA CCC AGA GCA C, Sox10 rev: CTC TGT CTT
TGG GGT GGT TG; p75NTR fw: CTA GGG GTG TCC TTT
GGA GGT, p75NTR rev: CAG GGT TCA CAC ACG GTC T;
Brn2 fw: GCA GCG TCT AAC CAC TAC AGC, Brn2 rev: GCG
GTG ATC CAC TGG TGA G; GAPDH fw: CCA CCC CAG
CAA GGA GAC T; GAPDH rev: GAA ATT GTG AGG GAG
ATG CT; Dicer fw: ACC AGC GCT TAG AAT TCC TGG
GAG; Dicer rev: GCA GCA GAC TTG GCG ATC CTG TAG.
Western blot
Sciatic nerves were homogenized in nerve buffer (1%
Triton6100, 137 mM NaCl, 2 mM EDTA, 20 mM Tris HCl,
pH 8) using a polytron PT 3100 (kinematica). For analysis of 18-
and 4-day old mice three different lysates were used, each
containing nerves pooled from three mice with the respective
genotype of mixed gender. Protein concentration was determined
using the BCA protein assay (Pierce). Proteins were boiled in LDS
(Invitrogen) containing b-mercaptoethananol, and loaded onto a
NuPAGEH Novex Bis-Tris Gel (Invitrogen). After electrophore-
tical separation, proteins were blotted onto nitrocellulose mem-
branes (Schleicher & Schuell) using XCell II Blot Module
(Invitrogen). Membranes were blocked using TBST containing
Top-Block (Sigma), and decorated with antibodies against CNPase
(Abcam), MBP (Serotec), PMP22, and Ras (Abcam), Erk,
phospho-Erk, Akt, phospho-Akt (Cell Signaling Technology),
followed by incubation with the secondary anti-mouse IgG1 and
IgG2a (Zymed) or anti-rabbit, and anti-rat IgG (Calbiochem). We
visualized proteins using SuperSignal West Pico Chemilumines-
cent Substrate System (Pierce) and Amersham Hyperfilm ECL
films (GE Healthcare).
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Immunohistochemistry
Sciatic nerves were fixed in 4% formalin and embedded in
paraffin. For each genotype, at least four nerves were analyzed
(22-day old Dicerfl/fl Dhh-Cre+ and control Dicerwt/fl Dhh-Cre+
littermates). Longitudinal paraffin or frozen sections were
incubated with the following antibodies: anti-S100 (Dako), anti-
MIB1 (Dako), B220/CD45R for B-cells (Pharmingen), CD3 for T-
cells (clone SP7, NeoMarkers), CD68 for macrophages (Serotec) or
stained with haematoxylin-eosin. For detection of primary
antibodies, a Ventana machine was used according to the
manufacturer’s protocol. Mounted slides were analyzed on an
Axiophot microscope (Zeiss), equipped with a JVC digital camera
(KY-F70; 3CCD). Rabbit immunoglobulin fraction (Dako) served
as negative control for S100 staining (data not shown). For
assessing proliferation, 940–1400 nuclei per mouse were counted
and the ‘‘MIB1 index’’ was determined as the percentage of nuclei
positive for MIB1 immunohistochemistry. CD3- and CD68-
positive cells were quantified in relation to total number of nuclei.
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